HALO: Halozyme Therapeutics Cash on Hand per Share

Symbol and logo of brand halozyme.com (HALO)

Reliance on external suppliers and contract manufacturing organizations creates certain risks; however, the cash per share history of Halozyme Therapeutics (HALO) demonstrates capital resilience. The 9.39 metric confirms current liquidity levels, supported by the licensing of ENHANZE subcutaneous injection technology. Robotic laboratories enhance business efficiency by automating enzyme screening, thereby reducing operating expenses.

Cash per Share: Halozyme Therapeutics (HALO) for 07/04/2022 - 11/21/2026

Analytical breakdowns for Halozyme Therapeutics (HALO)

- stock price and consensus target price:
- market capitalization information:
Summary company analysis:Halozyme Inc. - HALO
Flagship merchandise of Halozyme Corp

Halozyme Therapeutics (HALO) maintains high financial resilience during market downturns due to its robust patent protection and high barriers to entry within the drug delivery sector. Daily analysis of cash per share enables real-time tracking of capital dilution resulting from issuances, revealing the actual liquidity per share and the risk of inefficiently utilizing excess reserves, which confirms the fundamental reliability of the model.

Key competitors

Cash Funds per Single Share ONC (BeiGene Corp)|Cash per Single Share RVMD (Revolution Medicines Corp)|Cash Calculated per Single Share AAPG|Cash Funds per Share CG Oncology Therapeutics CGON|Amount of Cash per Share URGN|BCAX: Cash per Single Share|PSNL: Cash Funds per Share|Erasca (ERAS) - Cash Funds per Share|DCTH - Cash Funds Calculated per Share|YMAB (Y-mAbs Corp) - Cash per Share|Cash per Single Share Aura Biosciences (AURA)|Cash Funds per Share Candel Therapeutics Inc. (CADL)|Cash per Single Share Accuray, Inc. ARAY|Cash Funds per Share sellaslifesciences.com SLS|Amount of Cash per Share ACTU|CTOR - Cash Funds per Share|Cash Funds Calculated per Share tuhurabio.com HURA|Protara Therapeutics, Inc. (TARA) - Cash Funds per Share|FATE: Cash Calculated per Single Share|WHWK (Aadi Bioscience, Inc.) - Cash per Share|TCRX (TScan Therapeutics) - Cash Calculated per Single Share|Cash Funds per Share Champions Oncology (CSBR)|Cash Funds Calculated per Share XBiotech USA|Cash Funds per Share CEL-SCI CVM|OS Therapies, Inc. (OSTX) - Cash on Hand per Share|RADX - Cash Funds per Share|ARTV - Cash per Share|Adlai Nortye Ltd (ANL) - Cash Funds per Share|Veru Pharma - Amount of Cash per Share|Cash Funds per Share Tempest Therapeutics Corp|Cash Funds per Single Share XLO (Xilio Therapeutics, Inc.)|Cash per Share RENB|MURA (Mural Oncology) - Amount of Cash per Share|Cash per Share KAPA (Kairos Pharma Ltd)|OKUR: Cash Funds per Single Share|GDTC: Cash per Single Share|CRIS - Cash per Share|APLM: Cash per Share|Cash on Hand per Share tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Cash per Share|Cash per Share Genprex Inc.|Cash per Share CLDI|Cash per Single Share Sunshine Biopharma, Inc. SBFM|Cash per Share XBIO (Xenetic Biosciences)|Amount of Cash per Share SLRX|PPBT - Cash Funds per Share|AONC (aoncology.com) - Cash Funds per Single Share|BGNE: Cash per Share|Checkpoint Therapeutics Inc (CKPT) - Cash per Share|ELEV (Elevation Oncology Inc.) - Cash per Share|icadmed.com (ICAD) - Cash Funds Calculated per Share|Cash per Share IKNA|NTBL (Notable Labs) - Amount of Cash per Share|Cash per Share VIRX (Viracta Therapeutics)|Cash Funds Calculated per Share MorphoSys AG (MOR)|NAYA Biosciences Corp - Cash per Share|Cash on Hand per Share ascentage.com